IBP
Installed Building Products, Inc.
IBP trails on the overall score without a compensating advantage in the available component scores.
NKE
NIKE, Inc.
NKE has the edge over IBP overall, supported by stronger valuation and stronger modeled upside.
IBP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
IBP's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
IBP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $151 | -33% |
| Fair | 24x | $214 | -4.3% |
| Forward | 24x | $224 | — |
| Current | 26x | $224 | — |
| Expensive | 33x | $292 | +31% |
Historical ranges are pointers, not guarantees.
IBP's PE is in its fair range at 26x. On analysts' estimates for next year's earnings, today's price would be 24x.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over IBP in the historical PE scenario, which offers more potential upside but is not a forecast.
IBP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Decline | |
| Stable | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect IBP's earnings and profitability to decline, with its revenue holding steady.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
IBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.38 | +6.9% |
| Q3 2026 | $8.77 | -5.6% |
| Q2 2026 | $9.27 | +3.1% |
| Q1 2026 | $9.36 | +6.7% |
| Q4 2025 | $9.71 | +6.7% |
| Q3 2025 | $9.29 | +3.2% |
| Q2 2025 | $8.99 | +0.3% |
| Q1 2025 | $8.77 | -0.8% |
| Q4 2024 | $9.10 | +5.7% |
IBP has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
IBP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $808.4M | +3.9% |
| Q2 2026 | $777.8M | +2.3% |
| Q1 2026 | $660.5M | -3.5% |
| Q4 2025 | $747.5M | -0.4% |
| Q3 2025 | $778.2M | +2.3% |
| Q2 2025 | $760.3M | +3.1% |
| Q1 2025 | $684.8M | -1.2% |
| Q4 2024 | $750.2M | +4.1% |
IBP has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -2.4 points |
| Q2 2026 | 12% | -1.1 points |
| Q1 2026 | 8.7% | -1.5 points |
| Q4 2025 | 15% | +1.4 points |
| Q3 2025 | 14% | +0.4 points |
| Q2 2025 | 13% | +0.4 points |
| Q1 2025 | 10% | -2.5 points |
| Q4 2024 | 13% | -0.4 points |
IBP has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
IBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $58.3M | -44% |
| Q2 2026 | $51.9M | -31% |
| Q1 2026 | $85.7M | +19% |
| Q4 2025 | $49.3M | -6.8% |
| Q3 2025 | $104.8M | +36% |
| Q2 2025 | $74.8M | +29% |
| Q1 2025 | $71.9M | +14% |
| Q4 2024 | $52.9M | -29% |
IBP has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
IBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -206K shares |
| 1 year | -2.5% | -666K shares |
| 3 years | -6.4% | -1.8M shares |
| 5 years | -11% | -3.1M shares |
| Available history | -11% | -3.4M shares |
IBP has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $76.3M |
| Q1 2026 | $25.4M |
| Q4 2025 | $37.7M |
| Q3 2025 | $51.4M |
| Q2 2025 | $49.2M |
| Q1 2025 | $34.3M |
| Q4 2024 | $78.9M |
IBP spent $139M buying back its own shares over the past year, down 35% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
IBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.3x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 1.3x | Healthy |
IBP's net debt is about 1.5 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over IBP on leverage, with a lower net debt burden relative to earnings.
IBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 55.5 | Neutral |
IBP's weekly RSI is 50 (neutral) and its Stochastic is 55 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
IBP PE vs Consumer Cyclical Sector
| Metric | IBP | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 18x | 42% above |
| PE % | 52 | 47 | 5 pts above |
IBP is trading at 26x earnings, a 42% premium to the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over IBP on valuation relative to its sector.
IBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.6 | 10% above |
| 20 week MA | $218.5 | 2.4% above |
| 50 week MA | $249.9 | 10% below |
| 100 week MA | $227.4 | 1.6% below |
| 200 week MA | $201.6 | 11% above |
IBP has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
IBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.1 | $108.7 | +57% |
| 2021 | $108.7 | $139.0 | +28% |
| 2022 | $139.0 | $87.5 | -37% |
| 2023 | $87.5 | $182.8 | +109% |
| 2024 | $182.8 | $174.3 | -4.6% |
| 2025 | $174.3 | $267.2 | +53% |
| 2026 YTD | $267.2 | $223.8 | -16% |
IBP has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.